Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6408 posts found.

ny

How the intended role of generic medicines is being undermined in America

April 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, US, feature, generic medicines, generics

The introduction of a generic medicine should, in theory, incentivise companies to lower the price of the original drug, creating healthy …
Feature
800px-rhesus_macaque_macaca_mulatta_in_kinnarsani_ws_ap_w_img_5792

Gilead’s remdesivir significantly reduces COVID-19 symptoms in rhesus monkeys in NIH trial

April 20, 2020 Business Services, Medical Communications, Sales and Marketing COVID-19, Gilead, National Institutes of Health, coronavirus, remdesivir

A study from the National Institutes of Health has shed more light on the efficacy of Gilead’s promising antiviral therapy …
News
fda

FDA cautions that drug reviews will be slower due to COVID-19

April 17, 2020 Medical Communications COVID-19, FDA, coronavirus

The FDA has warned that they may not be able to sustain its current levels of timely reviews and approvals …
News
moderna-605x340

US Government’s BARDA to fund Moderna’s coronavirus vaccine by $483m

April 17, 2020 Medical Communications, Research and Development BARDA, COVID-19, Moderna, coronavirus, pharma

Moderna has secured $483 million in funding from the Biomedical Advanced Research and Development Authority (BARDA), to drive development and …
News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

April 17, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10

Hydroxychloroquine dominates the news as the potential COVID-19 treatment has gone through various trials. A Chinese study showed that the …
News

Leaked data show Gilead’s remdesivir allows severe COVID-19 patients to be discharged after six days

April 17, 2020 Medical Communications, Research and Development COVID-19, Gilead, coronavirus, remdesivir

The clinical benefit of Gilead’s promising antiviral therapy Remdesivir has been touted in the treatment of severe cases of COVID-19 …
News
inzulin

Governor of Minnesota signs emergency bill for insulin access

April 17, 2020 Medical Communications diabetes, insulin, insulin copays, medical insurance

Minnesota Governor Tim Walz has signed legislation to provide a one-time, 30-day supply of insulin for eligible residents in urgent …
News

Patient Experience: Living with type 1 diabetes

April 14, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Interview, diabetes, feature, patient experience

23-year-old US student Madelyn Lazra recently graduated with a BA in Business Law and certification in International Business, and is …
Feature
cdc_coronavirus_0

Pharmafile.com’s weekly COVID-19 news round-up

April 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus

The world looks for a coronavirus cure as Inovio begins human trials for a vaccine while another vaccine is in …
News
dr_molk

Seres Therapeutics appoints Dr Lisa von Moltke as new Chief Medical Officer

April 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Dr Lisa von Moltke has left Aklermes and has joined Seres Therapeutics as its new Chief Medical Officer. Chief Executive …
Appointment
90ten_team_photo

Envision Pharma Group acquires healthcare comms consultancy 90TEN

April 9, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 90TEN, Envision Pharma Group, pharma

Global healthcare communications consultancy 90TEN has been acquired by Envision Pharma Group, it has been revealed. 90TEN said that it …
News
mcintyre-headshot

Dr Maritza McIntyre appointed Chief Development Officer at StrideBio

April 8, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

StrideBio have announced the appointment of Maritza McIntyre Ph.D., as its first Chief Development Officer. The newly created role will …
Appointment
david_setboun

Industry veteran Dr David Setboun joins BrainStorm as Executive VP and COO

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BrainStorm Therapeutics, appointments, pharma

BrainStorm Cell Therapeutics, a firm developing cellular therapies to tackle neurodegenerative diseases, has named industry Big Pharma veteran Dr David …
Appointment
john-mckew-big

Dr John C. McKew promoted to Chief Operating Officer at Lumos Pharma

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Lumos Pharma, Inc. has promoted Dr John McKew to the position of Chief Operating Officer effective 1 April 2020. McKew …
Appointment
alimera_sciences_logo

Steven T Gill returns to Alimera as VP, Thought Leader Engagement

April 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alimera Sciences, Novartis, pharma

Ophthalmology specialist Alimera Sciences has announced that Steven T Gill is to return to the company in the newly created …
Appointment
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026